英文名稱 |
中文名稱 |
CAS號 |
操作 |
2'-(methylsulfanyl)[1,1'-biphenyl]-2-ylamine |
|
73671-44-0 |
詳細
|
CDK9-IN-12 |
|
1942843-54-0 |
詳細
|
Avotaciclib trihydrochloride |
|
1983984-01-5 |
詳細
|
Telaglenastat hydrochloride |
|
1874231-60-3 |
詳細
|
5-HT7R antagonist 1 free base |
|
2337008-64-5 |
詳細
|
SK&F 95601 |
|
103949-62-8 |
詳細
|
HG-7-85-01 |
|
1258391-13-7 |
詳細
|
Samelisant |
|
1394808-20-8 |
詳細
|
E67-2 |
|
1364914-62-4 |
詳細
|
2-(((4-(Benzyloxy)benzyl)(4-fluorobenzyl)amino)methyl)-1H-imidazole-5-carboxylic acid |
|
1382722-47-5 |
詳細
|
1H-Pyrazole-4-carboxamide, 1-(4-cyanophenyl)-N-(3-fluorophenyl)-3-[4-(methylsulfonyl)phenyl]- |
|
2204230-40-8 |
詳細
|
BPK-25 |
|
2305052-86-0 |
詳細
|
HPK1-IN-8 |
|
1214561-09-7 |
詳細
|
RORγ agonist 1 |
|
2260631-91-0 |
詳細
|
mGluR5 modulator 1 |
|
1261171-52-1 |
詳細
|
ATR-IN-9 |
|
2417513-43-8 |
詳細
|
Benzoic acid, 4-[[2-[[5-bromo-4-(4-cyclopropyl-1-naphthalenyl) -4H-1,2,4-triazol -3-yl]thio]acetyl]amino]-3-chloro- |
|
878670-61-2 |
詳細
|
nAChR agonist CMPI hydrochloride |
|
2250025-94-4 |
詳細
|
ALDH1A2-IN-1 |
|
2204229-64-9 |
詳細
|
2-Pyridinecarboxamide, N-[2-[4-amino-3-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]- |
|
1354825-03-8 |
詳細
|
Sovilnesib |
|
2410796-79-9 |
詳細
|
2-Naphthalenol, 6-(2-methoxy-5-pyrimidinyl)- |
|
2585198-85-0 |
詳細
|
Plazinemdor |
|
2378285-59-5 |
詳細
|
3-Quinolinecarboxylic acid, 6-[[(2S)-2-[([1,1'-biphenyl]-4-ylcarbonyl)amino]-1-oxopropyl]amino]-1,4-dihydro-4-oxo- |
|
2580935-57-3 |
詳細
|
JAK-IN-15 |
|
1973485-05-0 |
詳細
|
[1,2,4]Triazolo[1,5-a]pyrimidine, 7-(4-ethyl-1-piperazinyl)-5-methyl-2-[(2-methyl-1-piperidinyl)methyl]- |
|
1359415-02-3 |
詳細
|
2-Pyridinecarbonitrile, 6-(2,3-dihydro-2-methyl-3-oxo-1H-isoindol-5-yl)-5-[1-[(1-methylcyclopentyl)methyl]-1H-pyrazol-4-yl]- |
|
2102194-04-5 |
詳細
|
ALK2-IN-4 succinate |
|
2416307-25-8 |
詳細
|
Urea, N-[5,5-bis(4-fluorophenyl)pentyl]-N'-[4-nitro-3-(trifluoromethyl)phenyl]- |
|
2410612-08-5 |
詳細
|
CDK7-IN-5 |
|
1817006-50-0 |
詳細
|
LY 56110 |
|
26766-37-0 |
詳細
|
5H-Pyrazolo[4,3-c]pyridine-5-carboxamide, 3-[7-(difluoromethyl)-3,4-dihydro-6-(1-methyl-1H-pyrazol-4-yl)-1(2H)-quinolinyl]-1,4,6,7-tetrahydro-N-methyl-1-(4-piperidinyl)- |
|
2484741-78-6 |
詳細
|
Acetamide, N-[3-[[5-chloro-2-[[5-(4-methyl-1-piperazinyl)-2-pyridinyl]amino]-4-pyrimidinyl]amino]phenyl]- |
|
2414373-55-8 |
詳細
|
5-chloro-4-N-(4-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine |
|
1197953-88-0 |
詳細
|
JAK-2/3-IN-1 |
|
1036241-36-7 |
詳細
|
Glucagon Receptor Antagonist, Control |
|
362482-00-6 |
詳細
|
3'-(N-(3-((2-(2-(Dimethylamino)benzamido)ethyl)amino)phenyl)sulfamoyl)-4'-methoxy-N,N-dimethyl-[1,1'-biphenyl]-3-carboxamide dihydrochloride , YNT-185 2HCl |
|
1804978-82-2 |
詳細
|
PROTAC CDK6 ligand 1 |
|
2366269-23-8 |
詳細
|
Vevorisertib |
|
1416775-46-6 |
詳細
|
mGluR2 antagonist 1 |
|
1432728-49-8 |
詳細
|
Propanamide, N-[5-[[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino]-2-methylphenyl]- |
|
2470424-39-4 |
詳細
|
ALK5 Inhibitor II (hydrochloride) |
|
2319939-07-4 |
詳細
|
RapiFluor-MS |
|
1429047-69-7 |
詳細
|
2-Propenamide, N-[(2,3-dichlorophenyl)methyl]-N-[4-phenoxy-3-(trifluoromethyl)phenyl]- |
|
2305052-77-9 |
詳細
|
BRK inhibitor P21d hydrochloride |
|
2250025-98-8 |
詳細
|
Benzamide, 2-(3-aminopropoxy)-5-chloro-N-(1,1-dioxidobenzo[b]thien-6-yl)-, hydrochloride (1:1) |
|
2415263-08-8 |
詳細
|
GSK2332255B |
|
1366233-41-1 |
詳細
|
4-[2-[(6-Amino-9-b-D-ribofuranosyl-9H-purin-2-yl)thio]ethyl]benzenesulfonic acid ammonium salt |
|
2122196-16-9 |
詳細
|
NVP-BSK805 Trihydrochloride |
|
2320258-95-3 |
詳細
|
JMS 17-2 hydrochloride |
|
2341841-07-2 |
詳細
|
Prexasertib dimesylate |
|
1234015-58-7 |
詳細
|
ML 315 hydrochloride |
|
2172559-91-8 |
詳細
|
SAR247799 |
|
1315311-14-8 |
詳細
|
Benzonitrile, 4-(8-cyclopropyl-6,7,8,9-tetrahydro-9-oxopyrido[2',3':4,5]pyrrolo[1,2-a]pyrazin-10-yl)-2-fluoro- |
|
2055776-17-3 |
詳細
|
4-Piperidinecarboxylic acid, 1-[1-(2-chloro-6-cyclopropylbenzoyl)-4-fluoro-1H-indazol-3-yl]-3-hydroxy-, (3S,4R)- |
|
1561770-72-6 |
詳細
|
Venadaparib hydrochloride |
|
1681020-60-9 |
詳細
|
HDAC1/2-IN-3 |
|
2121516-17-2 |
詳細
|
6-Prenyl-1H-indole |
|
23158-16-9 |
詳細
|
CP 346086 Dihydrate |
|
1262769-98-1 |
詳細
|
IRE1α kinase-IN-2 |
|
1414938-21-8 |
詳細
|
6-Phenanthridinamine, 8-(trifluoromethyl)- |
|
651055-83-3 |
詳細
|
JNJ-67569762 |
|
2380313-26-6 |
詳細
|
4-Amino-5-chloro-N-[[4-[[1-(2-hydroxyacetyl)-4-piperidinyl]methyl]-2-morpholinyl]methyl]-2-methoxybenzamide |
|
1184662-02-9 |
詳細
|
Pheleuin |
|
169195-23-7 |
詳細
|
Oxazosulfyl |
|
1616678-32-0 |
詳細
|
CAY10742 |
|
1649473-91-5 |
詳細
|
EP4 receptor antagonist 3 |
|
1207954-34-4 |
詳細
|
KS15 |
|
1033781-20-2 |
詳細
|
XMU-MP-3 |
|
2031152-08-4 |
詳細
|
DDR1-IN-5 |
|
2416022-90-5 |
詳細
|
2H-1-Benzopyran-3-carboxamide, N-[3-(4-fluorophenyl)propyl]-7-hydroxy-2-oxo- |
|
2136579-33-2 |
詳細
|
Filapixant |
|
1948232-63-0 |
詳細
|
1H-Imidazole-4-carboxamide, N-[(1S)-2-amino-1-(3-chloro-5-fluorophenyl)ethyl]-1-[5-methyl-2-[(tetrahydro-2H-pyran-4-yl)amino]-4-pyrimidinyl]-, compd. with benzenesulfonate (1:1) |
|
2055597-39-0 |
詳細
|
1H-Pyrazole-3-methanol, 1-[2-[[[2-(4-amino-1-piperidinyl)-8-(1-methylethyl)pyrazolo[1,5-a]-1,3,5-triazin-4-yl]amino]methyl]-3-chlorophenyl]-α,α-dimethyl- |
|
2378710-04-2 |
詳細
|
111Benzamide,4-[3-[[(2R)-2-hydroxy-2-phenylethyl]amino]-3-methylbutyl]-, monohydrochloride(9CI) |
|
111112-18-6 |
詳細
|
N-(2-Hydroxyethyl)-4-methyl-2-((4-methyl-1H-indol-3-yl)thio)pentamide |
|
1027997-01-8 |
詳細
|
Br-PBTC |
|
1839519-57-1 |
詳細
|
AZ 1729 |
|
2016864-46-1 |
詳細
|
(S)-CVN424 |
|
1799968-74-3 |
詳細
|
Y12196 |
|
1671025-91-4 |
詳細
|
MYC-IN-2 |
|
2244979-61-9 |
詳細
|
Acid Ceramidase-IN-1 |
|
2415225-30-6 |
詳細
|
ATX inhibitor 7 |
|
1646784-47-5 |
詳細
|
LysoFP-NH2 |
|
69408-85-1 |
詳細
|
Amdizalisib |
|
1894229-05-0 |
詳細
|
Fluphenazine-N-2-chloroethane (hydrochloride) |
|
3892-78-2 |
詳細
|
AP26113 |
|
1197958-53-4 |
詳細
|
Risovalisib |
|
1494684-28-4 |
詳細
|
PIP4K-IN-a131 |
|
2055405-95-1 |
詳細
|
Edaxeterkib |
|
1695534-88-3 |
詳細
|
CD73-IN-5 |
|
2412019-99-7 |
詳細
|
Benzenemethanamine, 4-[4-chloro-3-(1H-indol-6-yl)-1H-pyrrolo[2,3-b]pyridin-1-yl]-N,N-dimethyl- |
|
2471981-21-0 |
詳細
|
6-Quinolinecarboxamide, 2-amino-3-methyl-N-[(7R)-4,5,6,7-tetrahydro-1H-indazol-7-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]- |
|
2691869-52-8 |
詳細
|
2-Propanol, 1-[[(2,4-difluorophenyl)methyl](phenylmethyl)amino]-3-(2-furanylmethoxy)- |
|
1048244-34-3 |
詳細
|
JNK3 inhibitor-1 |
|
2622877-97-6 |
詳細
|
2-amino-N-[[4-(5-bromopyrimidin-2-yl)oxy-3-chloro-phenyl]carbamoyl]ben zamide |
|
134742-26-0 |
詳細
|
(S)-UFR2709 |
|
1431628-22-6 |
詳細
|
Mesdopetam |
|
1403894-72-3 |
詳細
|
1H-Pyrazol-5-ol, 1-(5-chloro-2-pyridinyl)-3-phenyl- |
|
2579696-72-1 |
詳細
|
Enpatoran hydrochloride |
|
2101945-93-9 |
詳細
|